AzTrials
AzTrials

StrokeNCT03814460

Stroke and Assessment of Muscle Tone

An observational study of Stroke and Muscle Tone Abnormalities, run by University of Seville at 2 sites in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Spasticity is defined as a state of increased muscle tone, which evokes an increased resistance to a passive and fast stretching of the muscle. Indeed, the degree of spasticity depends, among other things, on the stretching velocity performed to the muscle. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Stroke, Muscle Tone Abnormalities, Pain
What is being tested?
Assessment of Tone, Pain and Thickness
How many people
65 participants
Where
2 sitesSpain
Study dates
2 Feb 2019to 25 Aug 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Participants with acute or chronic stroke will be recruited from large public hospitals. The control participants will be selected from the same population-based cohort

Who may be able to join

  • Be older than 18 years
  • Clinical diagnosis of stroke, confirmed using a MRI.
  • No previous history of other strokes.
  • Increases muscle tone in upper and lower extremities (punctuation equal to or superior to 1 in the Tardieu Scale, Ashworth Scale)
  • Ability to understand the study goals, follow simple instructions and provide informed consent.
  • Score equal to or superior to 24 in the Minimental State Examination.

Who cannot join

  • Any other confirmed neurological disorder that may influence muscle tone (multiple sclerosis, Parkinson, muscle dystrophies...)
  • A chronic musculoskeletal disorder in the upper or lower limb.
  • Previous history of surgery in the upper or lower extremities.
  • Changes in the medication intake that may affect muscle tone assessments in the 48 hours before data collection.
  • Having received botulin toxin in gastrocnemius or biceps brachii muscles in the 30 days before data collection.
  • A concomitant acute infection during data collection.
  • A previous epileptic crisis in the week before the study or during the study.

Trial locations and contacts

2 sites in 1 country.

Spain2 sites
  • Physiotherapy Department, University of Seville

    Seville, 41009

  • University of Sevilla

    Seville, 41009

Other trials in Spain

About this study

Official title: Stroke and Myotonometer: Validity, Reliability and Discrimination Between the Mechanical and Sensory Component of Spasticity

Spasticity is defined as a state of increased muscle tone, which evokes an increased resistance to a passive and fast stretching of the muscle. Indeed, the degree of spasticity depends, among other things, on the stretching velocity performed to the muscle. However, most of the tools used in the clinical setting to assess spasticity do not take into account the relationship between increased muscle tone and speed of stretching. Instead of that, muscle tone is usually assessed in a relaxed position of the muscle.

Likewise, to date, despite the functional disabilities related to the presence of chronic pain after a stroke, no previous study has correlated muscle tone and pressure pain sensitivity within this population

Being tested
Assessment of Tone, Pain and Thickness
Keywords
Topographical mapping, Muscle state of tension, Myotonometer, Pressure Pain Threshold, Muscle Thickness
Medical subject headings
Stroke, Pain, Muscle Spasticity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Assessment of Tone, Pain and ThicknessDiagnostic test

    Evaluation of Muscle state of tension, self-reported response to mechanical pressure pain and muscle thickness. The evaluation process of muscle tone and pressure pain sensitivity will be carried out following a topographical mapping covering myotendinous and muscle belly sites in the biceps brachii and the gastrocnemius muscles

Study groups in NCT03814460
Study groupRoleWhat they receive
Control GroupA control group of healthy subjects with no previous history of neurological disorders or conditions. This group pf participants will be selected in a similar population based-cohort than the other two study groups.
Receives: Diagnostic Test: Assessment of Tone, Pain and Thickness
Acute Stroke GroupIn this group, participants who suffered a previous stroke within 3 months before data collection will be included.
Receives: Diagnostic Test: Assessment of Tone, Pain and Thickness
Chronic Stroke GroupIn this group, only participants who have suffered a previous stroke of more than 3 months duration before data collection will be included.
Receives: Diagnostic Test: Assessment of Tone, Pain and Thickness

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pressure Pain Threshold, assessed by Manual Pressure Algometry

    A handheld electronic pressure algometer with a 1-cm2 contact probe will be used. Pressure pain thresholds (PPTs), as the minimum necessary pressure force to evoke pain, will be assessed bilaterally over biceps brachii and the gastrocnemius muscles (medial and lateral). Assessments will be made using a topographical mapping covering myotendinous and muscle belly sites in the above mentioned muscles. A 30-second break will be used between assessments to prevent bruising, and an average of the two measures over each site will be calculated for the statistical analysis. Pressure algometry is reliable in healthy individuals, and in stroke patients

    Measured: One time assessment

  2. Muscle Tone Assessment, using the modified Tardieu Scale

    The modified Tardieu Scale is the most common tool used in the clinical setting to evaluate the muscle tone. The muscle response to a slow and fast stretching will be performed. During the fast stretching, the joint angle in which the muscle responds with difficulty will be collected using an electrogoniometer.

    Measured: One time assessment

Secondary outcomes (3)
  1. Muscle Stiffness, assessed by a myotonometer

    The stiffness of the biceps brachii and gastrocnemius muscles will be collected using a handheld myotonometer device, the so-called MyotonPRO, (Myoton AS, Estonia). The MyotonPRO is small, non-invasive, and it has shown good validity and high reliability in larger and smaller body muscles. This device delivers a multi-scan mode of three brief mechanical impulses, each one shortly followed by a quick release, to record the damped natural oscillation of the muscle using an accelerometer.

    Evaluations will be made in the affected and non-affected sides of stroke patients and in dominant and non-dominant sides of control participants.

    Measured: One time assessment

  2. Muscle State of Tension (Muscle Tone), assessed by a myotonometer

    The tone of the biceps brachii and gastrocnemius muscles will be collected using a handheld myotonometer device, the MyotonPRO, (Myoton AS, Estonia). The MyotonPRO is small, non-invasive, and it has shown good validity and high reliability in larger and smaller body muscles. This device delivers a multi-scan mode of three brief mechanical impulses, each one shortly followed by a quick release, to record the damped natural oscillation of the muscle using an accelerometer.

    Evaluations will be made in the affected and non-affected sides of stroke patients and in dominant and non-dominant sides of control participants.

    Measured: One time assessment

  3. Muscle Thickness

    The thickness of the assessed muscles will be evaluated using ecography. Muscle thickness will be assessed in one point corresponding to a myotendinous site and one point corresponding to a muscle belly location in both, the biceps brachii and gastrocnemius muscles.

    Evaluations will be made in the affected and non-affected sides of stroke patients and in dominant and non-dominant sides of control participants.

    Measured: One time assessment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jan 2019
  2. Study start2 Feb 2019
  3. Primary completion25 Aug 2019
  4. Study completion25 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
65 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03814460
Sponsor's protocol ID
Myoton18
Status last verified
Sep 2019
First submitted
21 Jan 2019
Last updated
23 Sep 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Muscle Tone Abnormalities, run by University of Seville at 2 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pressure Pain Threshold, assessed by Manual Pressure Algometry (time frame: One time assessment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2019; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in